Form D · Pharmaceuticals
MERRIMACK PHARMACEUTICALS INC
Cambridge, MA · CIK 0001274792
Offering snapshot reported Apr 13, 2011 · SEC filing
- Reported sold
- $77M Offering amount: $77M
- Investors reported
- 61 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2011 | Initial | $77,000,000 | No comparison | 61 | SEC filing |
| Nov 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 7, 2006 | Paper | Not reported | No comparison | Not reported | |
| Feb 17, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158327
Source: Form D, filed Apr 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Crocker | Director |
| James Dresser | Director |
| Gordon Fehr | Director |
| Robert Gay | Director |
| Walter Lovenberg | Director |
| Robert J. Mulroy | Director, Executive |
| Sarah Nash | Director |
| Michael Porter | Director |
| Anthony Sinskey | Director |
| William A. Sullivan | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Kendall Square Suite B7201
Cambridge, MA, 02139
Cambridge, MA, 02139